Biomedical journals lack a consistent method to detect outcome reporting bias: a cross-sectional analysis von Huan, L. N., Tejani, A. M., Egan, G.

Volltext

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreat... von O'Neil, B H, Scott, A J, Ma, W W, Cohen, S J, Aisner, D L, Menter, A R, Tejani, M A, Cho, J K, Granfortuna, J, Coveler, L, Olowokure, O O, Baranda, J C, Cusnir, M, Phillip, P, Boles, J, Nazemzadeh, R, Rarick, M, Cohen, D J, Radford, J, Fehrenbacher, L, Bajaj, R, Bathini, V, Fanta, P, Berlin, J, McRee, A J, Maguire, R, Wilhelm, F, Maniar, M, Jimeno, A, Gomes, C L, Messersmith, W A

Volltext

Early results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + pembrolizumab therapy in patients (Pts) with relapsed/refractory gastric/gastroesophageal junction (GEJ) adenocarcinoma von Harvey, R.D., Murphy, A., Kim, E., Tejani, M.A., Wu, W., Pham, E.L., Muhsin, M.

Volltext

Finding independent information on new drugs von Tejani, AM

Volltext

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreat... von O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, A.L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.

Volltext

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreat... von O'Neil, B.H., Scott, A.J., Ma, W.W., Cohen, S.J., Leichman, L., Aisner, D.L., Menter, A.R., Tejani, M.A., Cho, J.K., Granfortuna, J., Coveler, L., Olowokure, O.O., Baranda, J.C., Cusnir, M., Phillip, P., Boles, J., Nazemzadeh, R., Rarick, M., Cohen, D.J., Radford, J., Fehrenbacher, L., Bajaj, R., Bathini, V., Fanta, P., Berlin, J., McRee, A.J., Maguire, R., Wilhelm, F., Maniar, M., Jimeno, A., Gomes, C.L., Messersmith, W.A.

Volltext

Pharmacotherapy for hypertension in adults 60 years or older von Musini, Vijaya M, Tejani, Aaron M, Bassett, Ken, Puil, Lorri, Wright, James M, Musini, Vijaya M

Volltext

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma von Mohamed, Mostafa, MD, Katz, Alan W., MD, MPH, Tejani, Mohamedtaki A., MD, Sharma, Ashwani K., MD, Kashyap, Randeep, MD, Noel, Marcus S., MD, Qiu, Haoming, MD, Hezel, Aram F., MD, Ramaraju, Gopal A., MD, Dokus, M. Katherine, MPH, Orloff, Mark S., MD

Volltext

New Evidence Regarding the Management of Hypertension von Tejani, A.M., Musini, V., Wright, J.M.

Volltext

170PEarly results of pegvorhyaluronidase alfa (PEGPH20; PVHA) + pembrolizumab therapy in patients (Pts) with relapsed/refractory gastric/gastroesophageal junction (GEJ) adenocarcin... von Harvey, R D, Murphy, A, Kim, E, Tejani, M A, Wu, W, Pham, E L, Muhsin, M

Volltext

Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study von Gewandter, Jennifer S., Chaudari, Jenna, Ibegbu, Chinazom, Kitt, Rachel, Serventi, Jennifer, Burke, Joy, Culakova, Eva, Kolb, Noah, Sluka, Kathleen A., Tejani, Mohamedtaki A., Mohile, Nimish A.

Volltext

Osteoporosis guidelines miss big picture von Vos, Eddie

Volltext

Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused von Becerra, Adan Z., BA, Probst, Christian P., MD, Tejani, Mohamedtaki A., MD, Aquina, Christopher T., MD, González, Maynor G., PhD, Hensley, Bradley J., MD, MBA, Noyes, Katia, PhD, MPH, Monson, John R.T., MD, Fleming, Fergal J., MD

Volltext

Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis von Fortin, Patricia M, Tejani, Aaron M, Bassett, Ken, Musini, Vijaya M

Volltext

ERCC1 and RRM1 expression in resected pancreatic adenocarcinoma von Tejani, M. A., Cai, K. Q., Zhu, F., Dubyk, C., Chun, Y. S., Cohen, S. J., Hoffman, J. P., Burtness, B.

Volltext

Risk-benefit profile of inhaled corticosteroids in COPD is still unclear von Turgeon, Ricky D, Tejani, Aaron M

Volltext

No better than less expensive drugs von Perry, Thomas L, Lippman, Stephen S, McConnell, Mark, Tejani, Aaron M

Volltext

Probiotics for preventing urinary tract infections in adults and children von Schwenger, Erin M, Tejani, Aaron M, Loewen, Peter S, Tejani, Aaron M

Volltext

Loop diuretics for patients receiving blood transfusions von Sarai, Michael, Tejani, Aaron M, Tejani, Aaron M

Volltext

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, dou... von Catenacci, Daniel V T, Tebbutt, Niall C, Davidenko, Irina, Murad, André M, Al-Batran, Salah-Eddin, Ilson, David H, Tjulandin, Sergei, Gotovkin, Evengy, Karaszewska, Boguslawa, Bondarenko, Igor, Tejani, Mohamedtaki A, Udrea, Anghel A, Tehfe, Mustapha, De Vita, Ferdinando, Turkington, Cheryl, Tang, Rui, Ang, Agnes, Zhang, Yilong, Hoang, Tien, Sidhu, Roger, Cunningham, David

Volltext